Unichem Laboratories: Board Meeting Outcome for Outcome Of Board Meeting

Purchase of Product approvals and all goodwill associated with Nine (9) ANDAs owned by Bayshore Pharmaceuticals LLC USA for USD 2 650 000 by the Company and Purchase of USA generics formulations business as a going concern through slump sale ./ transfer of business by Unichem Pharmaceuticals (USA) Inc through assets purchase agreements for USD 10 000 000.